Life Technologies Corporation
About Life Technologies
Ion Torrent has developed a DNA sequencing system that directly translates chemical signals (A, C, G, T) into digital information (0, 1) on a semiconductor chip. The result is a sequencing system that is simpler, faster, more cost effective and scalable than any other technology available. Because Ion Torrent produces its proprietary semiconductor chips in standard CMOS factories, we leverage the $1 trillion dollar investment that has been made in the semiconductor industry over the past 40 years. This enables us to directly benefit from four decades of exponential improvement in semiconductor technology, usually expressed as Moore's Law.
The company was founded in August 2007 by Jonathan Rothberg, a pioneer of high-speed, massively parallel DNA sequencing. Ion Torrent is based in Guilford, Connecticut with offices in San Francisco. Ion Torrent will launch the Ion Personal Genome Machine sequencer in 2010.
- Focus : Manufacturer
- Employees: 10,001+
- Industry : Biotechnology
News about Life Technologies
16-Apr-2013 | business & finance
Thermo Fisher Scientific to Acquire Life Technologies Corporation
Thermo Fisher Scientific and Life Technologies Corporation have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for ...
22-Jun-2011 | business & finance
BAC BV collaborates with Life Technologies to provide new HPLC affinity columns
BAC BV has announced a strategic collaboration with Life Technologies to bring the wide range of BAC’s CaptureSelect® affinity ligand specificities to Life ...
06-Jun-2011 | science
DNA Sequencing Data Reveals New Hybrid E. coli Strain is Cause of German Outbreak
Life Technologies Corporation announced that preliminary data from DNA sequencing performed in cooperation with the University Hospital Muenster, Germany, ...
19-Aug-2010 | business & finance
CEVEC Signs Global License Agreement for Human CAP-T Technology with Life Technologies
CEVEC Pharmaceuticals announced the signing of a co-exclusive worldwide licensing agreement with Life Technologies Corporation. Under the terms of the ...
11-Jun-2010 | business & finance
GENEART AG and Applied Biosystems Deutschland GmbH intend to conclude a domination agreement
GENEART AG and its majority shareholder, Applied Biosystems Deutschland GmbH, intend to conclude a domination agreement pursuant to Section 291 et seq. ...
19-Apr-2010 | business & finance
Management Board and Supervisory Board of GENEART Recommends Acceptance of Voluntary Public Offer
The Management Board and the Supervisory Board of GENEART AG have announced their joint statement with respect to the voluntary public offer by Applied ...
09-Apr-2010 | business & finance
GENEART AG will become part of the US-Based Biotechnology Company Life Technologies Corp.
Life Technologies acquires 58 % of GENEART shares via it´s German subsidiary Applied Biosystems Deutschland GmbH